vs

Side-by-side financial comparison of AVINO SILVER & GOLD MINES LTD (ASM) and AVITA Medical, Inc. (RCEL). Click either name above to swap in a different company.

AVINO SILVER & GOLD MINES LTD is the larger business by last-quarter revenue ($21.0M vs $17.6M, roughly 1.2× AVITA Medical, Inc.). AVINO SILVER & GOLD MINES LTD runs the higher net margin — 36.6% vs -66.0%, a 102.6% gap on every dollar of revenue. On growth, AVINO SILVER & GOLD MINES LTD posted the faster year-over-year revenue change (44.0% vs -4.3%). Over the past eight quarters, AVINO SILVER & GOLD MINES LTD's revenue compounded faster (51.1% CAGR vs 26.0%).

Avino Silver & Gold Mines Ltd is a Canada-based mining company engaged in the exploration, development, and production of precious and base metals, primarily silver, gold, and copper. It operates its flagship Avino Mine property in Durango, Mexico, with its metal products supplied to global industrial and commodity markets.

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East...

ASM vs RCEL — Head-to-Head

Bigger by revenue
ASM
ASM
1.2× larger
ASM
$21.0M
$17.6M
RCEL
Growing faster (revenue YoY)
ASM
ASM
+48.3% gap
ASM
44.0%
-4.3%
RCEL
Higher net margin
ASM
ASM
102.6% more per $
ASM
36.6%
-66.0%
RCEL
Faster 2-yr revenue CAGR
ASM
ASM
Annualised
ASM
51.1%
26.0%
RCEL

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ASM
ASM
RCEL
RCEL
Revenue
$21.0M
$17.6M
Net Profit
$7.7M
$-11.6M
Gross Margin
47.1%
81.2%
Operating Margin
-59.1%
Net Margin
36.6%
-66.0%
Revenue YoY
44.0%
-4.3%
Net Profit YoY
558.9%
-0.3%
EPS (diluted)
$0.05
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASM
ASM
RCEL
RCEL
Q4 25
$17.6M
Q3 25
$21.0M
$17.1M
Q2 25
$21.8M
$18.4M
Q1 25
$18.8M
$18.5M
Q4 24
$18.4M
Q3 24
$14.6M
$19.5M
Q2 24
$14.8M
$15.2M
Q1 24
$12.4M
$11.1M
Net Profit
ASM
ASM
RCEL
RCEL
Q4 25
$-11.6M
Q3 25
$7.7M
$-13.2M
Q2 25
$2.9M
$-9.9M
Q1 25
$5.6M
$-13.9M
Q4 24
$-11.6M
Q3 24
$1.2M
$-16.2M
Q2 24
$1.2M
$-15.4M
Q1 24
$599.0K
$-18.7M
Gross Margin
ASM
ASM
RCEL
RCEL
Q4 25
81.2%
Q3 25
47.1%
81.3%
Q2 25
46.9%
81.2%
Q1 25
56.1%
84.7%
Q4 24
87.6%
Q3 24
39.1%
83.7%
Q2 24
31.8%
86.1%
Q1 24
18.9%
86.4%
Operating Margin
ASM
ASM
RCEL
RCEL
Q4 25
-59.1%
Q3 25
-53.6%
Q2 25
-60.5%
Q1 25
-63.9%
Q4 24
-54.1%
Q3 24
-70.6%
Q2 24
-102.8%
Q1 24
-155.0%
Net Margin
ASM
ASM
RCEL
RCEL
Q4 25
-66.0%
Q3 25
36.6%
-77.3%
Q2 25
13.1%
-53.9%
Q1 25
29.8%
-74.9%
Q4 24
-63.0%
Q3 24
8.0%
-82.9%
Q2 24
8.4%
-101.3%
Q1 24
4.8%
-168.0%
EPS (diluted)
ASM
ASM
RCEL
RCEL
Q4 25
$-0.37
Q3 25
$0.05
$-0.46
Q2 25
$0.02
$-0.38
Q1 25
$0.04
$-0.53
Q4 24
$-0.44
Q3 24
$0.01
$-0.62
Q2 24
$0.01
$-0.60
Q1 24
$0.00
$-0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASM
ASM
RCEL
RCEL
Cash + ST InvestmentsLiquidity on hand
$57.3M
$18.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$182.1M
$-16.6M
Total Assets
$221.9M
$56.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASM
ASM
RCEL
RCEL
Q4 25
$18.2M
Q3 25
$57.3M
$23.3M
Q2 25
$37.3M
$15.7M
Q1 25
$26.6M
$25.8M
Q4 24
$35.9M
Q3 24
$7.8M
$44.4M
Q2 24
$5.3M
$54.1M
Q1 24
$3.5M
$68.2M
Stockholders' Equity
ASM
ASM
RCEL
RCEL
Q4 25
$-16.6M
Q3 25
$182.1M
$-6.7M
Q2 25
$144.8M
$-12.9M
Q1 25
$132.3M
$-4.6M
Q4 24
$4.5M
Q3 24
$114.5M
$12.2M
Q2 24
$112.2M
$23.9M
Q1 24
$107.8M
$32.6M
Total Assets
ASM
ASM
RCEL
RCEL
Q4 25
$56.4M
Q3 25
$221.9M
$63.7M
Q2 25
$174.7M
$58.1M
Q1 25
$157.7M
$69.6M
Q4 24
$79.7M
Q3 24
$135.4M
$81.1M
Q2 24
$133.7M
$87.8M
Q1 24
$128.6M
$97.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASM
ASM
RCEL
RCEL
Operating Cash FlowLast quarter
$8.3M
$-5.4M
Free Cash FlowOCF − Capex
$-6.1M
FCF MarginFCF / Revenue
-34.7%
Capex IntensityCapex / Revenue
3.8%
Cash ConversionOCF / Net Profit
1.08×
TTM Free Cash FlowTrailing 4 quarters
$-33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASM
ASM
RCEL
RCEL
Q4 25
$-5.4M
Q3 25
$8.3M
$-5.2M
Q2 25
$8.3M
$-10.2M
Q1 25
$758.0K
$-10.3M
Q4 24
$-8.1M
Q3 24
$4.1M
$-7.2M
Q2 24
$1.1M
$-12.8M
Q1 24
$2.3M
$-20.9M
Free Cash Flow
ASM
ASM
RCEL
RCEL
Q4 25
$-6.1M
Q3 25
$-6.2M
Q2 25
$-10.8M
Q1 25
$-10.5M
Q4 24
$-9.7M
Q3 24
$-11.0M
Q2 24
$-15.4M
Q1 24
$-22.0M
FCF Margin
ASM
ASM
RCEL
RCEL
Q4 25
-34.7%
Q3 25
-36.1%
Q2 25
-58.4%
Q1 25
-56.9%
Q4 24
-52.7%
Q3 24
-56.1%
Q2 24
-101.6%
Q1 24
-198.2%
Capex Intensity
ASM
ASM
RCEL
RCEL
Q4 25
3.8%
Q3 25
5.5%
Q2 25
2.8%
Q1 25
1.2%
Q4 24
8.8%
Q3 24
19.2%
Q2 24
17.5%
Q1 24
10.3%
Cash Conversion
ASM
ASM
RCEL
RCEL
Q4 25
Q3 25
1.08×
Q2 25
2.92×
Q1 25
0.13×
Q4 24
Q3 24
3.55×
Q2 24
0.87×
Q1 24
3.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons